The DOI matches its Crossref record; 299 of the 299 references it cites were found in a registry or an index.
CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands
Open accessAbstract
CC chemokines (or β-chemokines) are 28 chemotactic cytokines with an N-terminal CC domain that play an important role in immune system cells, such as CD4+ and CD8+ lymphocytes, dendritic cells, eosinophils, macrophages, monocytes, and NK cells, as well in neoplasia. In this review, we discuss human CC motif chemokine ligands: CCL1, CCL3, CCL4, CCL5, CCL18, CCL19, CCL20, CCL21, CCL25, CCL27, and CCL28 (CC motif chemokine receptor CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 ligands). We present their functioning in human physiology and in neoplasia, including their role in the proliferation, apoptosis resistance, drug resistance, migration, and invasion of cancer cells. We discuss the significance of chemokine receptors in organ-specific metastasis, as well as the influence of each chemokine on the recruitment of various cells to the tumor niche, such as cancer-associated fibroblasts (CAF), Kupffer cells, myeloid-derived suppressor cells (MDSC), osteoclasts, tumor-associated macrophages (TAM), tumor-infiltrating lymphocytes (TIL), and regulatory T cells (Treg). Finally, we show how the effect of the chemokines on vascular endothelial cells and lymphatic endothelial cells leads to angiogenesis and lymphangiogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–299 of 299
Chen, K., Liu, Q., Tsang, L. L., Ye, Q., Chan, H. C., Sun, Y., & Jiang, X. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.138 · Cited by 63
Sun, D., Luo, T., Dong, P., Zhang, N., Chen, J., Zhang, S., Dong, L., Janssen, H. L. A., & Zhang, S. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29514 · Cited by 63
Expression and function of the chemokine receptor CCR7 in thyroid carcinomas
Sancho, M., Vieira, J. M., Casalou, C., Mesquita, M., Pereira, T., Cavaco, B. M., Dias, S., & Leite, V. A. P. H. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06688 · Cited by 62
A novel p38-MAPK signaling axis modulates neutrophil biology in head and neck cancer
Dumitru, C. A., Fechner, M. K., Hoffmann, T. K., Lang, S., & Brandau, S. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0411193 · Cited by 61
MiR-345-5p functions as a tumor suppressor in pancreatic cancer by directly targeting CCL8
Mou, T., Xie, F., Zhong, P., Hua, H., Lai, L., Yang, Q., & Wang, J. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.121 · Cited by 61
Kadomoto, S., Izumi, K., Hiratsuka, K., Nakano, T., Naito, R., Makino, T., Iwamoto, H., Yaegashi, H., Shigehara, K., Kadono, Y., et al. (2019) · Cancers · doi:10.3390/cancers12010089 · Cited by 61
Wilson, J. L., Burchell, J., & Grimshaw, M. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1222 · Cited by 60
Johnson-Holiday, C. M., Singh, R., Johnson, E. L., Grizzle, W. E., Lillard, J. W., & Singh, S. (2011) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-9-46 · Cited by 59
Lai, J., Zhu, Y., Ruan, M., Chen, L., & Zhang, Q. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02857 · Cited by 59
Louahed, J., Struyf, S., Demoulin, J., Parmentier, M., Snick, J. V., Damme, J. V., & Renauld, J. (2003) · European Journal of Immunology · doi:10.1002/immu.200310025 · Cited by 58
Co-culture of Primary Human Mammary Fibroblasts and MCF-7 Cells as an In Vitro Breast Cancer Model
Heneweer, M. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfi025 · Cited by 58
CCL21/CCR7 Enhances the Proliferation, Migration, and Invasion of Human Bladder Cancer T24 Cells
Mo, M., Zhou, M., Wang, L., Qi, L., Zhou, K., Liu, L.-F., Chen, Z., & Zu, X.-B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119506 · Cited by 58
Baba, T., Naka, K., Morishita, S., Komatsu, N., Hirao, A., & Mukaida, N. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20130112 · Cited by 57
Datar, I. J., Qiu, X., Ma, H. Z., Yeung, M. L., Aras, S., de la Serna, I. L., Al‐Mulla, F., Thiery, J. P., Trumbly, R. J., Fan, X., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5176 · Cited by 57
Spinetti, G., Bernardini, G., Camarda, G., Mangoni, A., Santoni, A., Capogrossi, M. C., & Napolitano, M. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0302105 · Cited by 56
CCL28-induced RARβ expression inhibits oral squamous cell carcinoma bone invasion
Park, J., Zhang, X., Lee, S., Song, N., Son, S. H., Kim, K., Shim, J. H., Park, K.-K., & Chung, W. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125336 · Cited by 56
Colobrán, R., Pedrosa, E., Carretero-Iglesia, L., & Juan, M. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04224.x · Cited by 55
Chuang, C., Pan, M., Hou, M., & Hung, W. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24136 · Cited by 55
Plönes, T., Scholtes, B., Krohn, A., Burger, M., Passlick, B., Müller–Quernheim, J., & Zissel, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053068 · Cited by 55
Bonnotte, B., Crittenden, M. R., Larmonier, N., Gough, M. J., & Vile, R. G. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.8.4929 · Cited by 55
Botta, C., Martino, M. T. D., Ciliberto, D., Cucè, M., Correale, P., Rossi, M., Tagliaferri, P., & Tassone, P. (2016) · Blood Cancer Journal · doi:10.1038/bcj.2016.118 · Cited by 55
CCL18 enhances migration, invasion and EMT by binding CCR8 in bladder cancer cells
Liu, X., Xu, X., Deng, W., Huang, M., Wu, Y., Zhou, Z., Zhu, K., Wang, Y., Cheng, X.-F., Zhou, X., et al. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9791 · Cited by 55
CCL27/CCL28–CCR10 Chemokine Signaling Mediates Migration of Lymphatic Endothelial Cells
Karnezis, T., Farnsworth, R. H., Harris, N. C., Williams, S. P., Caesar, C., Byrne, D. J., Herle, P., Macheda, M. L., Shayan, R., Zhang, Y., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-1858 · Cited by 54
Miller, M. D., Wilson, S. D., Dorf, M. E., et al. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.8.2737 · Cited by 52
Biological and Clinical Significance of the CCR5/CCL5 Axis in Hepatocellular Carcinoma
Singh, S. K., Mishra, M. K., Rivers, B. M., Gordetsky, J., Bae, S., & Singh, R. (2020) · Cancers · doi:10.3390/cancers12040883 · Cited by 52
The orphan G‐protein‐coupled receptor 75 signaling is activated by the chemokine CCL 5
Dedoni, S., Campbell, L. A., Harvey, B. K., Avdoshina, V., & Mocchetti, I. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14463 · Cited by 51
Benkheil, M., Haele, M. V., Roskams, T., Laporte, M., Noppen, S., Abbasi, K., Delang, L., Neyts, J. H., & Liekens, S. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.09.023 · Cited by 51
CCR9–CCL25 interaction suppresses apoptosis of lung cancer cells by activating the PI3K/Akt pathway
Li, B., Wang, Z., Zhong, Y., Lan, J. X., Li, X., & Lin, H. (2015) · Medical Oncology · doi:10.1007/s12032-015-0531-0 · Cited by 50
Liu, Y., Wang, B., Qin, J., Zhou, H., Majumdar, A. P. N., & Peng, F. (2018) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2017.1417997 · Cited by 50
Gao, J., Tsuda, Y., Katayama, K., Nakayama, T., Hatanaka, Y., Tani, Y., Mizuguchi, H., Hayakawa, T., Yoshie, O., Tsutsumi, Y. M., et al. (2003) · PubMed · Cited by 48
Okada, N., Sasaki, A., Niwa, M., Okada, Y., Hatanaka, Y., Tani, Y., Mizuguchi, H., Nakagawa, S., Fujita, T., & Yamamoto, A. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700903 · Cited by 47
Baird, J. W., Nibbs, R. J. B., Komai‐Koma, M., Connolly, J. A., Ottersbach, K., Clark‐Lewis, I., Liew, F. Y., & Graham, G. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.47.33496 · Cited by 47
Yang, T., Chen, M., Yang, X., Zhang, X., Zhang, Z., Sun, Y., Xu, B., Hua, J., He, Z., & Song, Z. (2017) · Cancer Biology & Therapy · doi:10.1080/15384047.2017.1373219 · Cited by 47
Jiang, X. Y., Liu, J., Li, S., Jia, B., Huang, Z., Shen, J., Luo, H., & Zhao, J. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02978-w · Cited by 47
The chemokine receptor CCR7 promotes mammary tumorigenesis through amplification of stem-like cells
Boyle, S. T., Ingman, W. V., Poltavets, V., Faulkner, J. W., Whitfield, R. J., McColl, S. R., & Kochetkova, M. (2015) · Oncogene · doi:10.1038/onc.2015.66 · Cited by 45
Wolff, H. A., Rolke, D., Rave‐Fränk, M., Schirmer, M., Eicheler, W., Doerfler, A., Hille, A., Hess, C. F., Matthias, C., Rödel, R. M. W., et al. (2010) · Radiation and Environmental Biophysics · doi:10.1007/s00411-010-0341-x · Cited by 45
Iida, N., Nakamoto, Y., Baba, T., Kakinoki, K., Li, Y.-Y., Wu, Y., Matsushima, K., Kaneko, S., & Mukaida, N. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1107791 · Cited by 44
Wang, L.-H., Lin, C., Liu, S.-C., Liu, G., Chen, Y., Chen, J., Chan, C.-H., Lin, T.-Y., Chen, C.-K., Xu, G.-H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9213 · Cited by 44
Li, Z., Chan, K., Qi, Y., Lu, L., Ning, F., Wu, M., Wang, H., Wang, Y., Cai, S., & Du, J. (2018) · Cancer Research and Treatment · doi:10.4143/crt.2017.356 · Cited by 43
Nath, A., Chattopadhya, S., Chattopadhyay, U., & Sharma, N. K. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0149-3 · Cited by 43
Chen, D., Jiang, R., Mao, C., Shi, L., Wang, S., Yu, L., Hu, Q., Dai, D., & Xu, H. (2012) · Human Immunology · doi:10.1016/j.humimm.2012.07.333 · Cited by 43
Saha, J., Sarkar, D., Pramanik, A., Mahanti, K., Adhikary, A., & Bhattacharyya, S. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117731 · Cited by 43
Paracrine CCL20 loop induces epithelial‐mesenchymal transition in breast epithelial cells
Marsigliante, S., Vetrugno, C., & Muscella, A. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22360 · Cited by 42
Dynamics of regulatory T cells (Tregs) in patients with oral squamous cell carcinoma
Aggarwal, S., Sharma, S. C., & Das, S. N. (2017) · Journal of Surgical Oncology · doi:10.1002/jso.24782 · Cited by 42
Allen, F., Rauhe, P., Askew, D., Tong, A. A., Nthale, J. M., Eid, S. K., Myers, J., Tong, C., & Huang, A. Y.-C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01390 · Cited by 42
Hou, K. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i2.475 · Cited by 41
Chemokine CCL20 enhances the growth of HuH7 cells via phosphorylation of p44/42 MAPK in vitro
Fujii, H., Itoh, Y., Yamaguchi, K., Yamauchi, N., Harano, Y., Nakajima, T., Minami, M., & Okanoue, T. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.207 · Cited by 41
Liang, C., Zhong, C., Sun, R., Liu, B., Huang, C., Qin, J., Zhou, S. Y., Shan, J., Liu, Y., & Ye, S. (2007) · Journal of Virology · doi:10.1128/jvi.00208-07 · Cited by 41
Cancer cell CCL5 mediates bone marrow independent angiogenesis in breast cancer
Sax, M. J., Gasch, C., Athota, V. R., Freeman, R., Rasighaemi, P., Westcott, D. E., Day, C. J., Nikolić, I., Elsworth, B., Wei, M. Q., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13387 · Cited by 41
Expression of CCR8 is increased in asthma
Mutalithas, K., Guillén, C., Raport, C. J., Kolbeck, R., Soler, D., Brightling, C. E., Pavord, I. D., & Wardlaw, A. J. (2010) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2010.03504.x · Cited by 39
Leukemia cell infiltration causes defective erythropoiesis partially through MIP-1α/CCL3
Wang, Y., Gao, A., Zhao, H., Lu, P., Cheng, H., Dong, F., Gong, Y., Ma, S., Zheng, Y., Zhang, H., et al. (2016) · Leukemia · doi:10.1038/leu.2016.81 · Cited by 39
Yeh, C., Hsu, I., Song, W., Chang, H., Miyamoto, H., Xiao, G., Li, L., & Yeh, S. (2015) · PubMed · Cited by 39
Chen, Y., Tang, C. S., Zhang, M., Huang, W., Xu, Y. K., Sun, H.-Y., Yang, F., Song, L., Wang, H., Mu, L., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0458-0 · Cited by 39
Luo, A., Meng, M., Wang, G., Han, R. F., Zhang, Y., Jing, X., Zhao, L., Gu, S., & Zhao, X. (2020) · Journal of Breast Cancer · doi:10.4048/jbc.2020.23.e26 · Cited by 39
Muscella, A., Vetrugno, C., & Marsigliante, S. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22693 · Cited by 38
Baghel, K. S., Tewari, B. N., Shrivastava, R., Malik, S. A., Lone, M. D., Jain, N. K., Tripathi, C., Kanchan, R. K., Dixit, S., Singh, K., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1196299 · Cited by 37
Roy, I., Boyle, K. A., Vonderhaar, E. P., Zimmerman, N. P., Gorse, E., Mackinnon, A. C., Hwang, R. F., Franco‐Barraza, J., Cukierman, E., Tsai, S., et al. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2016.146 · Cited by 37
Sun, Y. N., Shao, J., Jiang, F., Wang, Y., Yan, Q., Yu, N., Zhang, J., Zhang, J., Li, M., & He, Y. (2018) · American Journal of Reproductive Immunology · doi:10.1111/aji.13067 · Cited by 36
Qian, X., Zhang, Q., Shao, N., Shan, Z., Cheang, T., Zhang, Z., Su, Q., Wang, S., & Lin, Y. (2019) · Europe PMC (PubMed Central) · Cited by 36
Su, M.-L., Chang, T., Chiang, C.-P., Chang, H.-C., Hou, M., Li, W., & Hung, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098823 · Cited by 35
Yamin, R., Kaynan, N., Glasner, A., Vitenshtein, A., Tsukerman, P., Bauman, Y., Ophir, Y., Elias, S., Bar‐On, Y., Gur, C., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003568 · Cited by 35
Wang, H., Liang, X., Li, M., Tao, X., Tai, S., Fan, Z., Wang, Z., Cheng, B., & Xia, J. (2017) · Cancer Science · doi:10.1111/cas.13289 · Cited by 35
Protein expression of the chemokine, CCL28, in human colorectal cancer
Dimberg, J., Hugander, A., & Wågsäter, D. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.2.315 · Cited by 34
Cytokine profile of breast cell lines after different radiation doses
Bravatà, V., Minafra, L., Forte, G. I., Cammarata, F. P., Russo, G. I., Maggio, F. M. D., Augello, G., Lio, D., & Gilardi, M. C. (2017) · International Journal of Radiation Biology · doi:10.1080/09553002.2017.1362504 · Cited by 33
Ma, W., Feng, L., Zhang, S., Zhang, H., Zhang, X., Qi, X., Zhang, Y., Feng, Q., Xiang, T., & Zeng, Y. (2018) · Cancer Science · doi:10.1111/cas.13584 · Cited by 32
Autocrine CCL5 promotes tumor progression in esophageal squamous cell carcinoma in vitro
Wu, Y., Shen, Y., Chang, J. W., Hsieh, J., Chu, Y., & Wang, C. (2018) · Cytokine · doi:10.1016/j.cyto.2018.04.027 · Cited by 30
Paracrine Activation of Chemokine Receptor CCR9 Enhances The Invasiveness of Pancreatic Cancer Cells
Heinrich, E. L., Arrington, A. K., Ko, M. E., Luu, C., Lee, W., Lu, J., & Kim, J. (2013) · Cancer Microenvironment · doi:10.1007/s12307-013-0130-6 · Cited by 29
Cheng, S., Lin, H. L., Guo, J., Yang, Q., Zhou, J., & Yang, X. (2014) · Tumor Biology · doi:10.1007/s13277-014-2540-6 · Cited by 28
Li, J., Liu, H., Li, L., Wu, H., Wang, C., YAN, Z., Wang, Y., Su, C., Jin, H., ZHOU, F., et al. (2012) · Oncology Reports · doi:10.3892/or.2012.2217 · Cited by 28
Induction of the MCP chemokine cluster cascade in the periphery by cancer cell-derived Ccl3
Farmaki, E., Kaza, V., Papavassiliou, A. G., Chatzistamou, I., & Kiaris, H. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.12.028 · Cited by 28
Interplay between CCR7 and Notch1 axes promotes stemness in MMTV-PyMT mammary cancer cells
Boyle, S. T., Gieniec, K. A., Whyte, C. E., Faulkner, J. W., McColl, S. R., & Kochetkova, M. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0592-0 · Cited by 28
CCL27/PESKY: a novel paradigm for chemokine function
Nibbs, R. J. B., & Graham, G. J. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.1.15 · Cited by 27
Fan, F., Wang, R., Boulbés, D. R., Zhang, H., Watowich, S. S., Xia, L., Ye, X., Bhattacharya, R., & Ellis, L. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190070 · Cited by 27
Chen, L., Liu, X., Zhang, H., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2134 · Cited by 26
Expression of the chemokine decoy receptor D6 is decreased in colon adenocarcinomas
Langenes, V., Svensson, H., Börjesson, L., Gustavsson, B. G., Bemark, M., Sjöling, Å., & Quiding‐Järbrink, M. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1472-0 · Cited by 25
Maghazachi, A. A., Sand, K. L., & Al‐Jaderi, Z. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00437 · Cited by 25
Brauß, T. F., Winslow, S., Lampe, S., Scholz, A., Weigert, A., Dehne, N., von Stedingk, K., Schmid, T., & Brüne, B. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22706 · Cited by 25
A Subset of CCL25-Induced Gut-Homing T Cells Affects Intestinal Immunity to Infection and Cancer
Fu, H., Jangani, M., Parmar, A., Wang, G., Coe, D., Spear, S., Sandrock, I., Capasso, M., Coles, M. C., Cornish, G. H., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00271 · Cited by 25
Wiedemann, G. M., Röhrle, N., Makeschin, M., Fesseler, J., Endres, S., Mayr, D. C., & Anz, D. (2019) · Pathology · doi:10.1016/j.pathol.2019.06.001 · Cited by 25
Luo, A., Meng, M., Wang, G., Han, R. F., Zhang, Y., Jing, X., Zhao, L., Gu, S., & Zhao, X. (2020) · Journal of Breast Cancer · doi:10.4048/jbc.2020.23.e54 · Cited by 25
NK cells are migrated and indispensable in the anti-tumor activity induced by CCL27 gene therapy
Gao, J., Tsuda, Y., Han, M. Y., Xu, D., Kanagawa, N., Hatanaka, Y., Tani, Y., Mizuguchi, H., Tsutsumi, Y. M., Mayumi, T., et al. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0554-x · Cited by 24
Wu, S., Lu, X., Zhang, Z. L., Lei, P., Yu, Y., Wang, M., Huang, B., Xing, W., Jiang, X., Liu, H. J., et al. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq265 · Cited by 24
Gene Expression Profiling of Chemokines and Their Receptors in Low and High Grade Astrocytoma
Sharma, I., Singh, A., Sharma, K. C., & Saxena, S. (2017) · PubMed Central · doi:10.22034/apjcp.2017.18.5.1307 · Cited by 24
Niu, Y., Tang, D., Fan, L., Gao, W., & Lin, H. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8635 · Cited by 24
Chen, B., ZHANG, D., Zhou, J., Li, Q., Zhou, L., LI, S.-M., Zhu, L., Chou, K.-Y., Zhou, L. F., Tao, L., et al. (2013) · Oncology Reports · doi:10.3892/or.2013.2603 · Cited by 23
Hypoxia modulates CCR7 expression in head and neck cancers
Basheer, H. A., Pakanavicius, E., Cooper, P. A., Shnyder, S. D., Martin, L., Hunter, K. D., Vinader, V. M., & Afarinkia, K. (2018) · Oral Oncology · doi:10.1016/j.oraloncology.2018.03.014 · Cited by 23
The expression of CCL18 in diffuse large B cell lymphoma and its mechanism research
Zhou, Q., Huang, L., Gu, Y., Lu, H., & Feng, Z. (2018) · Cancer Biomarkers · doi:10.3233/cbm-171097 · Cited by 22
Recruitment and significance of Th22 cells and Th17 cells in malignant ascites
Yang, X., Jiang, H., Lei, R., Lu, W., Tan, S., & Qin, S. (2018) · Oncology Letters · doi:10.3892/ol.2018.9316 · Cited by 20
Hua, F., & Tian, Y. (2017) · PubMed · Cited by 20
Du, H., Zhang, L., Li, G., Liu, W., Tang, W., Zhang, H., Luan, J. Y., Gao, L., & Wang, X. (2019) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2019.01.008 · Cited by 19
Ren, R., Yu, J., Zhang, Y., Wang, S.-F., Guo, X., Shen, M., Xu, M., Jiang, M., Zhi, Q., Chen, K., et al. (2019) · Pancreas · doi:10.1097/mpa.0000000000001386 · Cited by 19
Identification of a novel β-chemokine, MEC, down-regulated in primary breast tumors
Mickanin, C., Bhatia, U., & Labow, M. (2001) · International Journal of Oncology · doi:10.3892/ijo.18.5.939 · Cited by 18
Simon, P. S., Bardhan, K., Chen, M. R., Paschall, A. V., Lu, C., Bollag, R. J., Kong, F.-C., Jin, J., Kong, F., Waller, J. L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8246 · Cited by 18
Martinez-Rodriguez, M., Thompson, A. K., & Monteagudo, C. C. (2016) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2015-203537 · Cited by 17
Saito, M., Sejima, H., Naito, T., Ushirogawa, H., Matsuzaki, T., Matsuura, E., Tanaka, Y., Nakamura, T., & Takashima, H. (2017) · Virology Journal · doi:10.1186/s12985-017-0902-6 · Cited by 15
Complicated prognostic values of CCL28 in breast cancer by subtype
Gong, D.-H., Chen, Y., Ma, D., Chen, H., Ding, K., & Yu, K. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.02.26 · Cited by 15
[Role of chemokine CCL28 in hypoxia-induced migration of hepatocellular carcinoma].
Zhou, Y. F., Zhang, B., Yin, X. H., & Ren, Z. (2013) · PubMed · doi:10.3760/cma.j.issn.1007-3418.2013.07.012 · Cited by 7
Cheng, D.-E., Tsai, Y., Hsu, Y., Hou, M., Tsai, E., Wang, J., Kan, J., & Kuo, P. (2014) · Oncology Letters · doi:10.3892/ol.2014.2161 · Cited by 5
Hoerr, I. (2000) · doi:10.1002/1521-4141(200001)30:1
Cited by
Korbecki, J., Kojder, K., Simińska, D., Bohatyrewicz, R., Gutowska, I., Chlubek, D., & Baranowska-Bosiacka, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218412 · Cited by 465
Self-citationMacrophage Polarity and Disease Control
Kadomoto, S., Izumi, K., & Mizokami, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010144 · Cited by 318
Kidani, Y., Nogami, W., Yasumizu, Y., Kawashima, A., Tanaka, A., Sonoda, Y., Tona, Y., Nashiki, K., Matsumoto, R., Hagiwara, M., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2114282119 · Cited by 212
Zhao, F., He, Y., Zhao, Z., He, J., Huang, H., Ai, K., Liu, L., & Cai, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1272133 · Cited by 42
Metadata
- Authors
- Korbecki, J., Grochans, S., Gutowska, I., Barczak, K., & Baranowska-Bosiacka, I.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-10-15
- Volume
- 21
- Issue
- 20
- Pages
- 7619
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3093270998
- Cited by
- 373
- References
- 299
- FWCI
- 15.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.